I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
How safe are our studies? Analysis of adverse events in Bay..:
Jung, David
;
Boettcher, Michael-Friedrich
;
Wensing, Georg
Int. Journal of Clinical Pharmacology and Therapeutics. 58 (2020) 1 - p. 10-20 , 2020
Link:
https://doi.org/10.5414/cp203390
RT Journal T1 <Title>How safe are our studies? Analysis of adverse events in Bayer First-in-Human trials from 2006 to 2016</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.5414_cp203390&Exemplar=1&LAN=DE A1 Jung, David A1 Boettcher, Michael-Friedrich A1 Wensing, Georg PB Dustri-Verlgag Dr. Karl Feistle YR 2020 SN 0946-1965 JF Int. Journal of Clinical Pharmacology and Therapeutics VO 58 IS 1 SP 10 OP 20 LK http://dx.doi.org/https://doi.org/10.5414/cp203390 DO https://doi.org/10.5414/cp203390 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
